LDS/Medical Tests/ExoDx™ (IntelliScore) Prostate Test

ExoDx™ (IntelliScore) Prostate Test

Prostate cancer is the second leading cause of cancer in men accounting for approximately 13.3% of all new cancer diagnosed in the US. While PSA is the most widely used tumor marker for the screening and diagnosing prostate cancer, it has several limitations including its relatively low sensitivity for prostate cancer, inability to differentiate high grade from low grade lesions and that it may be elevated in non-cancerous conditions such as benign hypertrophy and prostatitis.

The ExoDx™ prostate (EPI) test is a noninvasive, urine-based, liquid biopsy test that measures exosomal RNA Ct value of three genes – PCA3 (prostate cancer antigen 3), ERG (V-ets erythroblastosis virus E26 oncogene homologs) and SPDEF (SAM pointed domain-containing Ets transcription factor). It has been suggested for use in men over 50-75 years of age with PSA results at grey zone (2-10 ng/mL) to help determine the need for prostate biopsy. Several studies have confirmed that the use of EPI test is associated with improved identification of patients with high-grade disease and can significantly reduce the total number of unnecessary biopsies.

The test has sensitivity of 92% and negative predictive value of 91% for prostate cancer. The EPI test is reported as a score ranging from 0 to 100 with a cutoff value of 15.6. A score above the cutoff is associated with an increased likelihood of high-grade prostate cancer (Gleason Score >7) on a biopsy.

  • Aid in diagnosis of prostate cancer
  • May be useful to determine the need for prostate biopsy when PSA level is 2-10 ng/mL
Scores from the ExoDx Prostate test range from 0 to 100, with the cutoff point at 15.6. The higher the score, the higher will be the likelihood of high-grade prostate cancer. EPI scores above 15.6 are more likely to need prostate biopsy.

EPI Score < 15.6

Gene expression array.

Urine (“first catch” urine sample, initial 15 mL).

Stability

  • Refrigerated: 14 days
Prostate-specific antigen (PSA) – Free and Total, PCA3, ConfirmMDx, Prostate biopsy.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login